Multimodal KCNQ1 Variant-Effect Maps Define Ion Channel Mechanisms and Disease Risk
Authors:
- M. Lorena HarveyMHM. Lorena Harvey
- Ellen OsbornEOEllen Osborn
- Megan C. LancasterMLMegan C. Lancaster
- Jeremy E. SmithJSJeremy E. Smith
- Qianyi ShenQSQianyi Shen
- Temidayo A. AbeTATemidayo A. Abe
- Ruoyi CaiRCRuoyi Cai
- Ayesha MuhammadAMAyesha Muhammad
- Rose KannankerilRKRose Kannankeril
- Tao YangTYTao Yang
- Maria E. CalandranisMCMaria E. Calandranis
- Daniel J. BlackwellDBDaniel J. Blackwell
- 20 October 2026
- journal article
- Published by Wolters Kluwer Health in Circulation
Abstract
BACKGROUND: Variants in the ion channel gene KCNQ1 are the leading cause of congenital long QT syndrome (LQTS), a disorder characterized by QT prolongation and risk of fatal arrhythmias. The expanding use of genetic testing has led to the identification of numerous variants of uncertain significance, complicating clinical interpretation and risk stratification. Functional characterization of KCNQ1 variants is essential to define their role in long QT syndrome and advance precision medicine in cardiovascular care. METHODS: We generated a nearly comprehensive variant library of 13 403 protein-coding variants in KCNQ1 . Using 4 pooled assays followed by high-throughput sequencing, we characterized the variants’ effects on cell surface abundance and channel function in both the variant-only and heterozygous states. Case–control analyses and data from large-scale biobanks were used to assess the clinical impact of loss-of-function variants on QT prolongation and long QT syndrome. Heterozygous assay results were used to determine dominant-negative effects, which were also evaluated for association with arrhythmia risk. Protein structural clustering of distinct classes of deleterious variants was analyzed. RESULTS: Across the 4 assays, we generated 49 305 functional measurements of KCNQ1 variants. Of the 13 403 KCNQ1 studied variants, 1757 demonstrated strong pathogenic evidence, and 6660 showed moderate benign evidence. Loss-of-function variants were significantly associated with QT prolongation and long QT syndrome in case–control and biobank analyses. Deleterious variants clustered within distinct structural domains based on their functional classification. A majority of pathogenic variants exhibited dominant-negative effects; these variants were linked to a higher risk of arrhythmia diagnoses than were haploinsufficient variants. CONCLUSIONS: This comprehensive KCNQ1 functional atlas provides novel functional evidence for most KCNQ1 variants of uncertain significance. It also reveals mechanistic principles linking genetic variation to ion channel biology and arrhythmia susceptibility, advancing cardiovascular precision medicine.Keywords
This publication has 101 references indexed in Scilit:
- European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseasesJournal of Arrhythmia, 2022
- Splicing predictions, minigene analyses, and ACMG‐AMP clinical classification of 42 germline PALB2 splice‐site variantsThe Journal of Pathology, 2021
- Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia GenesJAMA Cardiology, 2021
- Drug‐induced Proarrhythmia and Torsade de Pointes: A Primer for Students and Practitioners of Medicine and PharmacyThe Journal of Clinical Pharmacology, 2018
- Integrating electronic health record genotype and phenotype datasets to transform patient careClinical Pharmacology & Therapeutics, 2015
- Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell linesBiotechnology Journal, 2015
- Crystal structure of a trimeric form of the KV7.1 (KCNQ1) A‐domain tail coiled‐coil reveals structural plasticity and context dependent changes in a putative coiled‐coil trimerization motifProtein Science, 2009
- Genetic Testing in the Long QT SyndromeJAMA, 2005
- Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome.The EMBO Journal, 1996
- Practical statistics for medical research. Douglas G. Altman, Chapman and Hall, London, 1991. No. of pages: 611. Price: £32.00Statistics in Medicine, 1991